Semaglutide, the GLP-1 drug that Novo sells under the brand names Ozempic for diabetes and Wegovy for weight loss, has made ...

Rising numbers of people are needing hospital treatment for side effects from weight loss injections and it may be affecting ...

Investing.com -- Novo Nordisk (CSE: NOVOb) has been placed on JPMorgan’s Catalyst Watch list, signaling heightened anticipation as the company approaches a pivotal moment in its development pipeline.

FAT jabs such as Ozempic and Wegovy could be “game changers” in tackling bowel cancer within five years, researchers have claimed Evidence has already shown that injections of the weight-loss drugs ...

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), the kings of the titanic weight-loss drugs market, might have a problem ...

MORE than 12 Scots have been left in hospital after taking miracle fat loss jabs. The popular belly-busting injections have seen scores of people treated by medics for potentially dangerous side ...

Twelve Scots were rushed to A&E with complications from 'miracle' weight-loss injections in the same health board area where ...

As the battle against obesity and diabetes heats up, two new superstars are entering the ring in Spain - Mounjaro (also known ...

Analyzing H&H's Q3 results and investment strategy in the healthcare industry, highlighting undervaluation and raising the ...

Five University of Cambridge experts have shared their views on whether semaglutide-based drugs like Wegovy and Ozempic can ...

Unbelievable markdowns. A simple online search for semaglutide, the active ingredient in Ozempic or Wegovy, can lead consumers down a rabbit hole of seemingly reputable online pharmacies in search of ...